相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA
Maria Chiara Deregibus et al.
BLOOD (2007)
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors
Tanja Hakkarainen et al.
HUMAN GENE THERAPY (2007)
Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles
Brett Hall et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects
T. Wenger et al.
CANCER GENE THERAPY (2007)
Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector
S. Myhre et al.
GENE THERAPY (2007)
Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: A novel mechanism for phenotype modulation
Jason M. Aliotta et al.
STEM CELLS (2007)
Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs
Xian-cheng Chen et al.
CARCINOGENESIS (2006)
Adenovirus type 5 interactions with human blood cells may compromise systemic delivery
Mark Lyons et al.
MOLECULAR THERAPY (2006)
Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand
IM Germano et al.
JOURNAL OF NEUROSURGERY (2006)
Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)
Christian Schichor et al.
EXPERIMENTAL NEUROLOGY (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases
Bo-Ra Son et al.
STEM CELLS (2006)
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery
J Ratajczak et al.
LEUKEMIA (2006)
Current strategies and future directions for eluding adenoviral vector immunity
Dinesh S. Bangari et al.
CURRENT GENE THERAPY (2006)
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
S Komarova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Gene transfer into rat mesenchymal stem cells: A comparative study of viral and nonviral vectors
JM McMahon et al.
STEM CELLS AND DEVELOPMENT (2006)
Good manufacturing practice production of adenoviral vectors for clinical trials
M Lusky
HUMAN GENE THERAPY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Mesenchymal stem cells: clinical applications and biological characterization
FP Barry et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression
A Mohr et al.
GENE THERAPY (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect
JY Seol et al.
CANCER GENE THERAPY (2003)
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation
WT Tse et al.
TRANSPLANTATION (2003)
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
T Reid et al.
CANCER GENE THERAPY (2002)
Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line
L Zhang et al.
GENE THERAPY (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL
C Voelkel-Johnson et al.
CANCER GENE THERAPY (2002)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/apo-2 ligand gene induces tumor cell apoptosis
TS Griffith et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
